Budecort Inhaler 200 MD 100 mcg Cipla
€27.00
Understanding Budecort Inhaler 200 MD 100 mcg Cipla
Budecort Inhaler 200 MD 100 mcg Cipla is a pharmaceutical product primarily known for its role in managing respiratory conditions such as asthma and COPD. The active substance, Budesonide, is a potent corticosteroid that works by reducing inflammation in the airways, thereby enhancing breathing capacity and overall pulmonary function. Understanding its physiological role can clarify how this medication aids not just respiratory health but can indirectly influence other areas of physical performance.
The Mechanism of Budesonide
As a glucocorticoid, Budesonide engages in a complex mechanism that involves modulating inflammation at the cellular level. It acts on glucocorticoid receptors, suppressing the release of pro-inflammatory mediators and proteins. This activity plays a vital role in muscle recovery and injury prevention, making it relevant for athletes engaged in high-intensity sports. By mitigating inflammation, Budesonide can promote a more conducive environment for muscle hypertrophy and recovery.
Effects on Muscle Growth and Recovery
While Budesonide is not traditionally categorized as an anabolic substance, its anti-inflammatory properties can enhance muscle recovery rates post-exercise. Athletes often experience enhanced endurance and a quicker return to training capacity due to reduced muscle soreness and inflammation. Clinical studies have shown that effective management of inflammation through corticosteroids can positively affect overall performance metrics, such as endurance and muscle hypertrophy, albeit indirectly.
Influence on Fat Metabolism and Hormonal Regulation
Budesonide can also play a role in metabolic regulation. Corticosteroids have been studied for their effects on fat metabolism, though caution is advised due to the potential for increased fat deposition if misused. However, at prescribed dosages, Budecort may help balance metabolic processes, supporting a healthier body composition over time. Its influence on natural testosterone support is less direct but can be pivotal when considering a holistic approach to performance enhancement.
Typical Dosage and Duration for Use
The typical dosage range for Budecort Inhaler 200 MD 100 mcg Cipla is tailored according to individual needs, often starting at 200-400 mcg daily, depending on severity and duration of symptoms. Beginners are advised to consult healthcare professionals to find the optimal dosage without exceeding recommended limits. For intermediate users, maintaining awareness of personal tolerance and response is essential to maximize benefits safely and effectively.
Controlled Production and Responsible Usage
Cipla ensures that Budecort Inhaler is manufactured under strict quality controls, adhering to international standards to guarantee safety and effectiveness. Awareness of side effects, including potential hormonal imbalances or other negative impacts, should be prioritized. Users are encouraged to maintain responsible usage, respecting dosage guidelines and monitoring their body’s responses over time.
Your Next Step Toward Enhanced Performance
If you’re ready to maximize your performance safely, this is your next step. Consulting with a healthcare provider can clarify whether Budecort Inhaler 200 MD 100 mcg Cipla fits into your health and performance regimen. Empower your body’s potential and experience the scientifically backed results that come with informed choices.
| Active substance | Budesonide |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Not specific for standard drug tests |
| Strength | 100mcg |
| Also known as | Budesonidum |
| Blood pressure | Typically no effect on blood pressure |
| Trade name | Pulmicort, Rhinocort |
| Storage conditions | Store in a cool, dry place away from direct sunlight |
| Chemical name | (RS)-11ОІ,16О±,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde |
| Formula | C25H34O6 |
| Substance class | Corticosteroid |
| Main action | Anti-inflammatory |
| Half-life | 2 to 3.6 hours |
| Dosage (medical) | Inhalation (100 to 800 micrograms per day), Oral (9 mg per day), Nasal spray (256 micrograms per day) |
| Dosage (sports) | Not applicable |
| Effects | Reduces inflammation, suppresses immune response |
| Side effects | Oral thrush, hoarseness, cough, headache, nausea, adrenal suppression |
| Use in sports | Not commonly used, except for legitimate asthma treatment |
| Manufacturer | Cipla Ltd. |
| Packing | 1 Inhaler/pack |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |











Reviews
There are no reviews yet.